Comparación clínica y laboratorial de la fiebre amarilla severa versus dengue grave en Perú
Resumen
En los centros de Emergencia con poco apoyo de laboratorio, es difícil diferenciar a los pacientes con dengue grave y fiebre amarilla severa. El objetivo fue comparar el perfil clínico y de laboratorio de los pacientes con dengue grave y fiebre amarilla severa en Urgencias. Se realizó un estudio observacional retrospectivo de pacientes con diagnóstico confirmado de dengue y fiebre amarilla en el período 2018 a 2020 atendidos en la Unidad de Emergencia del Hospital Carrión, Huancayo-Perú. Se evaluaron un total de 35 pacientes, 11 pacientes (31,4%) fueron diagnosticados con fiebre amarilla severa y 24 pacientes (68,5%) con dengue grave. La media de los resultados de laboratorio con fiebre amarilla severa fueron bilirrubina indirecta 4,7 ml/dL, aspartato transaminasa 4463 UI/L, transaminasa aminotransferasa 4329 UI/L, creatinina 4,9 mg/dl. En pacientes con dengue grave el hematocrito promedio fue 51,8, hemoglobina 17,6 g/dl, plaquetas 24 × 103/mm. En pacientes con síndrome ictérico-febril la presencia de bradicardia, bilirrubina indirecta elevada y transaminasas muy elevadas debe hacer sospechar de fiebre amarilla; mientras que los pacientes que acuden por ascitis, derrame pleural, aumento de hematocrito y deficiencia de plaquetas, se debe tratar como dengue grave sobre todo en Unidades de Emergencia con poco apoyo de laboratorio.
Palabras clave
Texto completo:
PDFReferencias
AbuBakar, S., Puteh, S., Kastner, R., Oliver, L., Lim, S. H., Hanley, R., & Gallagher, E. (2022). Epidemiology (2012-2019) and costs (2009-2019) of dengue in Malaysia: a systematic literature review. International journal of infectious diseases, S1201-9712(22)00505-7. Advance online publication. https://doi.org/10.1016/j.ijid.2022.09.006
Acharya, S., Shukla, S., Sontakke, T., Vs, I., Bagga, C., Dronamraju, S., & Giri, A. (2022). A Case Report of Hemophagocytic Lymphohistiocytosis (HLH) - An Unusual Complication of Dengue Infection. Cureus, 14(7), e26504. https://doi.org/10.7759/cureus.26504
Aliaga-Samanez, A., Real, R., Segura, M., Marfil-Daza, C., & Olivero, J. (2022). Yellow fever surveillance suggests zoonotic and anthroponotic emergent potential. Communications biology, 5(1), 530. https://doi.org/10.1038/s42003-022-03492-9
Arantes, M. F., Seabra, V. F., Lins, P., Rodríguez, C. E., Reichert, B. V., Silveira, M., Li, H. Y., Malbouisson, L. M., & Andrade, L. (2021). Risk Factors for Acute Kidney Injury and Death in Patients Infected With the Yellow Fever Virus During the 2018 Outbreak in São Paulo, Brazil. Kidney international reports, 7(3), 601–609. https://doi.org/10.1016/j.ekir.2021.12.021
Araújo Lagos, L. W., Jesus Lopes de Abreu, A., Caetano, R., & Braga, J. U. (2022). Yellow fever vaccine safety in immunocompromised individuals: a systematic review and meta-analysis. Journal of travel medicine, taac095. Advance online publication. https://doi.org/10.1093/jtm/taac095
Arshad, H., Bashir, M., Mushtaq, U. S., Imtiaz, H., Rajpar, R., Alam, M. F., Fatima, S., Rehman, A., Abbas, K., & Talpur, A. S. (2022). Clinical Characteristics and Symptomatology Associated With Dengue Fever. Cureus, 14(7), e26677. https://doi.org/10.7759/cureus.26677
Bailey, A. L., Kang, L. I., de Assis Barros D'Elia Zanella, L., Silveira, C., Ho, Y. L., Foquet, L., Bial, G. (2020). Consumptive coagulopathy of severe yellow fever occurs independently of hepatocellular tropism and massive hepatic injury. Proceedings of the National Academy of Sciences of the United States of America, 117(51), 32648–32656. https://doi.org/10.1073/pnas.2014096117
Balasubramani, S., Govindaraj, V., Agarwal, R., Pathania, A., & Vij, A. (2022). COVID-19 Antibodies as Predictor of Severe Dengue among Hospitalized Children with Dengue Illness in the Post-third-wave Period of COVID-19 Infection in India. The Journal of the Association of Physicians of India, 70(9), 11–12. https://doi.org/10.5005/japi-11001-0092
Batra, N., Kaur, N., & Pethekar, A. (2022). Acute Kidney Injury in Dengue Fever: A One-year Hospital-based Prospective Cross-sectional Study. The Journal of the Association of Physicians of India, 70(6), 11–12. https://doi.org/10.5005/japi-11001-0024
Bhandari, S., Rankawat, G., Goyal, B., Lohmror, A., Gupta, V., & Singh, A. (2022). Establishment of SMS Dengue Severity Score. The Journal of the Association of Physicians of India, 70(9), 11–12. https://doi.org/10.5005/japi-11001-0095
Calderón-Peláez, M. A., Coronel-Ruiz, C., Castellanos, J. E., & Velandia-Romero, M. L. (2022). Endothelial Dysfunction, HMGB1, and Dengue: An Enigma to Solve. Viruses, 14(8), 1765. https://doi.org/10.3390/v14081765
Cohen, M., Nguyen, M., Nix, C. D., Case, B., Nickerson, J. P., Bernard, J., Durrant, J., Safarpour, D., Tucker, T., Vagnerova, K., & Messer, W. B. (2022). Case Report: Yellow Fever Vaccine-Associated Neurotropic Disease and Associated MRI, EEG, and CSF Findings. Frontiers in neurology, 12, 779014. https://doi.org/10.3389/fneur.2021.779014
Crochemore, T., Savioli, F. A., Guerra, J., & Kalmar, E. (2020). Thromboelastometry identifies coagulopathy associated with liver failure and disseminated intravascular coagulation caused by yellow fever, guiding specific hemostatic therapy: a case report. Revista Brasileira de terapia intensiva, 32(3), 474–478. https://doi.org/10.5935/0103-507X.20200078
De Almeida, I. F., Lana, R. M., & Codeço, C. T. (2022). How heterogeneous is the dengue transmission profile in Brazil? A study in six Brazilian states. PLoS neglected tropical diseases, 16(9), e0010746. Advance online publication. https://doi.org/10.1371/journal.pntd.0010746
Dostal, T., Meisner, J., Munayco, C., García, P. J., Cárcamo, C., Pérez Lu, J. E., Morin, C., Frisbie, L., & Rabinowitz, P. M. (2022). The effect of weather and climate on dengue outbreak risk in Peru, 2000-2018: A time-series analysis. PLoS neglected tropical diseases, 16(6), e0010479. https://doi.org/10.1371/journal.pntd.0010479
Esson, R., Rodrigues De Sousa, E., Benair, L., Devard, N., Soulet, D., Gillet, A., Bassard, I., Falque, S., Chareyre, A., Marmin, M., Girerd-Chambaz, Y., Logvinoff, C., & Navarro Sanchez, M. E. (2022). Phenotypic and genetic characterization of a next generation live-attenuated yellow fever vaccine candidate. Vaccine, 40(38), 5641–5650. https://doi.org/10.1016/j.vaccine.2022.07.043
García, M. P., Padilla, C., Figueroa, D., Manrique, C., & Cabezas, C. (2022). Emergence of the Cosmopolitan genotype of dengue virus serotype 2 (DENV2) in Madre de Dios, Peru, 2019. Emergencia del genotipo Cosmopolitan del virus dengue serotipo 2 (DENV2) en Madre de Dios, Perú, 2019. Revista peruana de medicina experimental y salud publica, 39(1), 126–128. https://doi.org/10.17843/rpmesp.2022.391.10861
Gehrke, F., Cardoso Gois, K., da Costa Alves Aguiar Reis, B., Zorello Laporta, G., & Affonso Fonseca, F. L. (2021). Dengue 2 serotype and yellow fever coinfection. Access microbiology, 3(12), 000300. https://doi.org/10.1099/acmi.0.000300
Guindo-Coulibaly, N., Kpan, M., Adja, A. M., Kouadio, A., Assouho, K. F., Zoh, D. D., Azongnibo, K., Remoue, F., & Fournet, F. (2022). Seasonal variation and intra urban heterogeneity of the entomological risk of transmission of dengue and yellow fever in Abidjan, Côte d'Ivoire. Medical and veterinary entomology, 36(3), 329–337. https://doi.org/10.1111/mve.12571
Guzmán J. (2018). Dengue Epidemiological Situation in Peru, to the SE 52-2017. 2018;26 (52):1628-30.
Ismail, S., Fildes, R., Ahmad, R., Wan Mohamad Ali, W. N., & Omar, T. (2022). The practicality of Malaysia dengue outbreak forecasting model as an early warning system. Infectious Disease Modelling, 7(3), 510–525. https://doi.org/10.1016/j.idm.2022.07.008
Kalimuddin, S., Teh, Y. E., Wee, L. E., Paintal, S., Sasisekharan, R., Low, J. G., Sheth, S. K., & Ooi, E. E. (2022). Chronic sequelae complicate convalescence from both dengue and acute viral respiratory illness. PLoS neglected tropical diseases, 16(8), e0010724. https://doi.org/10.1371/journal.pntd.0010724
Meregildo-Rodriguez, E. D., & Villegas-Chiroque, M. (2019). Jungle yellow fever with positive serology for leptospira in a young peruvian male. Revista peruana de medicina experimental y salud pública, 36(4), 700–704. https://doi.org/10.17843/rpmesp.2019.364.4347
MHM: Ministry of Health of Malaysia. (2021). Academy of Medicine of Malaysia. Clinical Practice guidelines on management of dengue infection in adults. Disponible en: www.acadmed.org.my/view_file.cfm?fileid=32
MINSA- National Center for Epidemiology, Disease Prevention and Control. Number of Yellow Fever cases. Peru 2000-2018. Disponible en: http://www.dge.gob.pe/portal/docs/vigilancia/sala/2018/SE52/f_amarilla.pdf.
Moras, E., Achappa, B., Murlimanju, B. V., Raj, G., Holla, R., Madi, D., D'Souza, N. V., & Mahalingam, S. (2022). Early diagnostic markers in predicting the severity of dengue disease. 3 Biotech, 12(10), 268. https://doi.org/10.1007/s13205-022-03334-9
Oyono, M. G., Kenmoe, S., Abanda, N. N., Takuissu, G. R., Ebogo-Belobo, J. T., Kenfack-Momo, R., Kengne-Nde, C. (2022). Epidemiology of yellow fever virus in humans, arthropods, and non-human primates in sub-Saharan Africa: A systematic review and meta-analysis. PLoS neglected tropical diseases, 16(7), e0010610. https://doi.org/10.1371/journal.pntd.0010610
Rodríguez-Morales, A. J., Bonilla-Aldana, D. K., Suárez, J. A., Franco-Paredes, C., Forero-Peña, D. A., Mattar, S., Villamil-Gómez. (2021). Yellow fever reemergence in Venezuela - Implications for international travelers and Latin American countries during the COVID-19 pandemic. Travel medicine and infectious disease, 44, 102192. https://doi.org/10.1016/j.tmaid.2021.102192
Santos, J. M., Capinha, C., Rocha, J., & Sousa, C. A. (2022). The current and future distribution of the yellow fever mosquito (Aedes aegypti) on Madeira Island. PLoS neglected tropical diseases, 16(9), e0010715. Advance online publication. https://doi.org/10.1371/journal.pntd.0010715
Srisuphanunt, M., Puttaruk, P., Kooltheat, N., Katzenmeier, G., & Wilairatana, P. (2022). Prognostic Indicators for the Early Prediction of Severe Dengue Infection: A Retrospective Study in a University Hospital in Thailand. Tropical medicine and infectious disease, 7(8), 162. https://doi.org/10.3390/tropicalmed7080162
Swamy, A. M., Mahesh, P. Y., & Rajashekar, S. T. (2021). Liver function in dengue and its correlation with disease severity: a retrospective cross-sectional observational study in a tertiary care center in Coastal India. The Pan African medical journal, 40, 261. https://doi.org/10.11604/pamj.2021.40.261.29795
Wakimoto, M. D., Camacho, L., Gonin, M. L., & Brasil, P. (2017). Clinical and Laboratory Factors Associated with Severe Dengue: A Case-Control Study of Hospitalized Children. Journal of Tropical Pediatrics, 64(5), 373-381. https://doi.org/10.1093/tropej/fmx078
World Health Organization - WHO. Report of Serious Dengue.2018; 10 (13). https://www.who.int/es/news-room/fact-sheets/detail/dengue-and-severe-dengue
World Health Organization - WHO. Yellow Fever Report. 2018; 05 (1). https://www.who.int/es/news-room/fact-sheets/detail/yellow-fever.
Enlaces refback
- No hay ningún enlace refback.
Copyright (c) 2022 Boletín de Malariología y Salud Ambiental